메뉴 건너뛰기




Volumn 26, Issue 4, 2012, Pages 740-745

Breakthroughs in anticoagulation: Advent of the oral direct factor Xa inhibitors

Author keywords

acute coronary syndromes; anticoagulation; apixaban; atrial fibrillation; edoxaban; factor X concentrate; factor Xa inhibition; hepatic biotransformation; hip arthroplasty; knee arthroplasty; mechanical heart valve; myocardial infarction; prothrombin complex concentrates; recombinant factor VIIa; renal dysfunction; rivaroxaban; secondary prevention; stroke; venous thromboembolism; vitamin K; xabans

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; APIXABAN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A INHIBITOR; CLOPIDOGREL; DABIGATRAN; EDOXABAN; ENOXAPARIN; FONDAPARINUX; PROTHROMBIN COMPLEX; RIVAROXABAN; THIENOPYRIDINE DERIVATIVE; WARFARIN;

EID: 84863460874     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2012.03.029     Document Type: Review
Times cited : (11)

References (52)
  • 2
    • 82255192497 scopus 로고    scopus 로고
    • Advances in anticoagulation: Focus on dabigatran, an oral direct thrombin inhibitor
    • J.G. Augoustides Advances in anticoagulation: Focus on dabigatran, an oral direct thrombin inhibitor J Cardiothorac Vasc Anesth 25 2011 1208 1212
    • (2011) J Cardiothorac Vasc Anesth , vol.25 , pp. 1208-1212
    • Augoustides, J.G.1
  • 3
    • 74949139434 scopus 로고    scopus 로고
    • The new oral anticoagulants
    • D. Garcia, E. Libby, M.A. Crowther The new oral anticoagulants Blood 115 2010 15 20
    • (2010) Blood , vol.115 , pp. 15-20
    • Garcia, D.1    Libby, E.2    Crowther, M.A.3
  • 4
    • 77954369172 scopus 로고    scopus 로고
    • New oral anticoagulation drugs in cardiovascular disease
    • I. Ahrens, G.Y. Lip, K. Peter New oral anticoagulation drugs in cardiovascular disease Thromb Haemost 104 2010 49 60
    • (2010) Thromb Haemost , vol.104 , pp. 49-60
    • Ahrens, I.1    Lip, G.Y.2    Peter, K.3
  • 5
    • 77952044405 scopus 로고    scopus 로고
    • Assessment of laboratory assays to measure rivaroxaban - An oral, direct factor Xa inhibitor
    • M.M. Samama, J.L. Martinoli, L. LeFiem Assessment of laboratory assays to measure rivaroxaban - An oral, direct factor Xa inhibitor Thromb Haemost 103 2010 815 825
    • (2010) Thromb Haemost , vol.103 , pp. 815-825
    • Samama, M.M.1    Martinoli, J.L.2    Lefiem, L.3
  • 6
    • 84856293397 scopus 로고    scopus 로고
    • Evaluation of the prothrombin time for measuring rivaroxaban plasma concentrations using calibrators and controls: Results of a multicenter field trial
    • [Epub ahead of print]
    • M.M. Samama, G. Contant, T.E. Spiro Evaluation of the prothrombin time for measuring rivaroxaban plasma concentrations using calibrators and controls: Results of a multicenter field trial Clin Appl Thromb/Hemost 2012 [Epub ahead of print]
    • (2012) Clin Appl Thromb/Hemost
    • Samama, M.M.1    Contant, G.2    Spiro, T.E.3
  • 7
    • 84856632988 scopus 로고    scopus 로고
    • Evaluation of anti-factor Xa chromogenic assay for the measurement of rivaroxaban concentrations using calibrators and controls
    • M.M. Samama, G. Contant, T.E. Spiro Evaluation of anti-factor Xa chromogenic assay for the measurement of rivaroxaban concentrations using calibrators and controls Thromb Haemost 107 2012 379 387
    • (2012) Thromb Haemost , vol.107 , pp. 379-387
    • Samama, M.M.1    Contant, G.2    Spiro, T.E.3
  • 8
    • 84856784474 scopus 로고    scopus 로고
    • Oral anticoagulation therapy: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
    • W. Ageno, A.S. Gallus, A. Wittkowsky Oral anticoagulation therapy: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 141 2012 e44S e88S
    • (2012) Chest , vol.141
    • Ageno, W.1    Gallus, A.S.2    Wittkowsky, A.3
  • 9
    • 80053571188 scopus 로고    scopus 로고
    • Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: A randomized, placebo-controlled, crossover study in healthy subjects
    • E.S. Ferenberg, P.W. Kamphuisen, M.K. Sijpkens Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: A randomized, placebo-controlled, crossover study in healthy subjects Circulation 124 2011 1573 1579
    • (2011) Circulation , vol.124 , pp. 1573-1579
    • Ferenberg, E.S.1    Kamphuisen, P.W.2    Sijpkens, M.K.3
  • 11
    • 84655176578 scopus 로고    scopus 로고
    • Evaluation of prothrombin complex concentrate and recombinant activated factor VIIa to reverse rivaroxaban in a rabbit model
    • A. Godier, A. Miciot, B. Le Bonniec Evaluation of prothrombin complex concentrate and recombinant activated factor VIIa to reverse rivaroxaban in a rabbit model Anesthesiology 116 2012 94 102
    • (2012) Anesthesiology , vol.116 , pp. 94-102
    • Godier, A.1    Miciot, A.2    Le Bonniec, B.3
  • 12
    • 84857730757 scopus 로고    scopus 로고
    • Prothrombin complex concentrate-related thrombotic risk following anticoagulation reversal
    • P. Toth, M. Makris Prothrombin complex concentrate-related thrombotic risk following anticoagulation reversal Thromb Haemost 107 2012 599
    • (2012) Thromb Haemost , vol.107 , pp. 599
    • Toth, P.1    Makris, M.2
  • 13
    • 84855326101 scopus 로고    scopus 로고
    • The year in cardiothoracic and vascular anesthesia: Selected highlights from 2011
    • P.A. Patel, H. Ramakrishna, M. Andritsos The year in cardiothoracic and vascular anesthesia: Selected highlights from 2011 J Cardiothorac Vasc Anesth 26 2012 3 10
    • (2012) J Cardiothorac Vasc Anesth , vol.26 , pp. 3-10
    • Patel, P.A.1    Ramakrishna, H.2    Andritsos, M.3
  • 17
    • 46049106502 scopus 로고    scopus 로고
    • Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: A double-blind, randomized controlled trial
    • A.K. Kakkar, B. Brenner, O.E. Dahl Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: A double-blind, randomized controlled trial Lancet 372 2008 31 39
    • (2008) Lancet , vol.372 , pp. 31-39
    • Kakkar, A.K.1    Brenner, B.2    Dahl, O.E.3
  • 18
    • 65549169515 scopus 로고    scopus 로고
    • Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): A randomized trial
    • A.G. Turpie, M.R. Lassen, B.L. Davidson Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): A randomized trial Lancet 373 2009 1673 1680
    • (2009) Lancet , vol.373 , pp. 1673-1680
    • Turpie, A.G.1    Lassen, M.R.2    Davidson, B.L.3
  • 19
    • 78649319886 scopus 로고    scopus 로고
    • Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: A meta-analysis of randomized controlled trials
    • Y.B. Cao, J.D. Zhang, H. Shen Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: A meta-analysis of randomized controlled trials Eur J Clin Pharmacol 66 2010 1099 1108
    • (2010) Eur J Clin Pharmacol , vol.66 , pp. 1099-1108
    • Cao, Y.B.1    Zhang, J.D.2    Shen, H.3
  • 20
    • 78650242199 scopus 로고    scopus 로고
    • Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials
    • M.V. Huisman, D.J. Quinlan, O.E. Dahl Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials Circ Cardiovasc Qual Outcomes 3 2010 6562 6660
    • (2010) Circ Cardiovasc Qual Outcomes , vol.3 , pp. 6562-6660
    • Huisman, M.V.1    Quinlan, D.J.2    Dahl, O.E.3
  • 21
    • 80052341686 scopus 로고    scopus 로고
    • Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patietns: MAGELLAN study protocol
    • A.T. Cohen, T.E. Spiro, H.R. Büller Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patietns: MAGELLAN study protocol J Thromb Thrombolysis 31 2011 407 416
    • (2011) J Thromb Thrombolysis , vol.31 , pp. 407-416
    • Cohen, A.T.1    Spiro, T.E.2    Büller, H.R.3
  • 22
    • 78650619315 scopus 로고    scopus 로고
    • Oral rivaroxaban for symptomatic venous thromboembolism
    • R. Bauersachs, S.D. Berkowitz, B. Brenner Oral rivaroxaban for symptomatic venous thromboembolism N Engl J Med 363 2010 2499 2510
    • (2010) N Engl J Med , vol.363 , pp. 2499-2510
    • Bauersachs, R.1    Berkowitz, S.D.2    Brenner, B.3
  • 23
    • 78650622643 scopus 로고    scopus 로고
    • Therapeutic potential of oral factor Xa inhibitors
    • E.M. Hylek Therapeutic potential of oral factor Xa inhibitors N Engl J Med 363 2010 2559 2561
    • (2010) N Engl J Med , vol.363 , pp. 2559-2561
    • Hylek, E.M.1
  • 25
    • 80051800555 scopus 로고    scopus 로고
    • New anticoagulants for prevention of stroke in patients with atrial fibrillation
    • J.F. Viles-Gonzalez, V. Fuster, J.L. Halperin New anticoagulants for prevention of stroke in patients with atrial fibrillation J Cardiovasc Electrophysiol 22 2011 948 955
    • (2011) J Cardiovasc Electrophysiol , vol.22 , pp. 948-955
    • Viles-Gonzalez, J.F.1    Fuster, V.2    Halperin, J.L.3
  • 26
    • 80052592404 scopus 로고    scopus 로고
    • Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    • M.R. Patel, K.W. Mahaffey, J. Garg Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
    • (2011) N Engl J Med , vol.365 , pp. 883-891
    • Patel, M.R.1    Mahaffey, K.W.2    Garg, J.3
  • 27
    • 80054896035 scopus 로고    scopus 로고
    • Evaluating rivaroxaban for nonvalvular atrial fibrillation - Regulatory considerations
    • T.R. Fleming, S.S. Emerson Evaluating rivaroxaban for nonvalvular atrial fibrillation - Regulatory considerations N Engl J Med 365 2011 1557 1559
    • (2011) N Engl J Med , vol.365 , pp. 1557-1559
    • Fleming, T.R.1    Emerson, S.S.2
  • 28
    • 84856745317 scopus 로고    scopus 로고
    • Antithrombotic therapy for atrial fibrillation: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    • J.J. You, D.E. Singer, P.A. Howard Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e531S e575S
    • (2012) Chest , vol.141
    • You, J.J.1    Singer, D.E.2    Howard, P.A.3
  • 29
    • 84855723464 scopus 로고    scopus 로고
    • A new era in secondary prevention after acute coronary syndrome
    • M.T. Roe, E.M. Ohman A new era in secondary prevention after acute coronary syndrome N Engl J Med 366 2012 85 87
    • (2012) N Engl J Med , vol.366 , pp. 85-87
    • Roe, M.T.1    Ohman, E.M.2
  • 30
    • 84857638418 scopus 로고    scopus 로고
    • Promise of factor Xa inhibition in acute coronary syndromes
    • L. Lee, D. Chew Promise of factor Xa inhibition in acute coronary syndromes Curr Cardiol Rep 14 2012 40 48
    • (2012) Curr Cardiol Rep , vol.14 , pp. 40-48
    • Lee, L.1    Chew, D.2
  • 31
    • 84862907587 scopus 로고    scopus 로고
    • Rivaroxaban in patients with a recent acute coronary syndrome
    • J.L. Mega, E. Braunwald, S.D. Wiviott Rivaroxaban in patients with a recent acute coronary syndrome N Engl J Med 366 2012 9 19
    • (2012) N Engl J Med , vol.366 , pp. 9-19
    • Mega, J.L.1    Braunwald, E.2    Wiviott, S.D.3
  • 32
    • 84859937777 scopus 로고    scopus 로고
    • Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves
    • [Epub ahead of print]
    • J.W. Eikelboom, R.G. Hart Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves Am J Hematol 2012 [Epub ahead of print]
    • (2012) Am J Hematol
    • Eikelboom, J.W.1    Hart, R.G.2
  • 33
    • 84858231144 scopus 로고    scopus 로고
    • Mechanical aortic valve replacement in young women planning on pregnancy: Maternal and fetal outcomes under low oral anticoagulation, a pilot observational study on a comprehensive pre-operative counseling protocol
    • L.S. De Santo, G. Romano, Corte A. Della Mechanical aortic valve replacement in young women planning on pregnancy: Maternal and fetal outcomes under low oral anticoagulation, a pilot observational study on a comprehensive pre-operative counseling protocol J Am Coll Cardiol 59 2012 1110 1115
    • (2012) J Am Coll Cardiol , vol.59 , pp. 1110-1115
    • De Santo, L.S.1    Romano, G.2    Della, C.A.3
  • 34
    • 80052700689 scopus 로고    scopus 로고
    • A prospective trial showing the safety of adjusted-dose enoxaparin for thromboprophylaxis of pregnant women with mechanical prosthetic heart valves
    • C.R. Saeed, J.B. Frank, M. Pravin A prospective trial showing the safety of adjusted-dose enoxaparin for thromboprophylaxis of pregnant women with mechanical prosthetic heart valves Clin Appl Thromb Hemost 17 2011 313 319
    • (2011) Clin Appl Thromb Hemost , vol.17 , pp. 313-319
    • Saeed, C.R.1    Frank, J.B.2    Pravin, M.3
  • 35
    • 84858033931 scopus 로고    scopus 로고
    • Successful use of fondaparinux for bridging early after aortic and mitral mechanical heart valve replacement
    • e9-e9
    • A.J. Perissinotti, B. Dotson, F.A. Baciewicz Successful use of fondaparinux for bridging early after aortic and mitral mechanical heart valve replacement Ann Pharmacother 46 2012 e9-e9
    • (2012) Ann Pharmacother , vol.46
    • Perissinotti, A.J.1    Dotson, B.2    Baciewicz, F.A.3
  • 36
    • 82955205748 scopus 로고    scopus 로고
    • Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: Results of an in vitro study
    • A. Kaeberich, I. Reindl, U. Raaz Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: Results of an in vitro study J Thromb Thrombolysis 32 2011 417 425
    • (2011) J Thromb Thrombolysis , vol.32 , pp. 417-425
    • Kaeberich, A.1    Reindl, I.2    Raaz, U.3
  • 37
    • 68249158084 scopus 로고    scopus 로고
    • Apixaban or enoxaparin for thromboprophylaxis after knee replacement
    • M.R. Lassen, G.E. Raskob, A. Gallus Apixaban or enoxaparin for thromboprophylaxis after knee replacement N Engl J Med 361 2009 594 604
    • (2009) N Engl J Med , vol.361 , pp. 594-604
    • Lassen, M.R.1    Raskob, G.E.2    Gallus, A.3
  • 38
    • 77649113258 scopus 로고    scopus 로고
    • Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): A randomized double-blind trial
    • M.R. Lassen, G.E. Raskob, A. Gallus Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): A randomized double-blind trial Lancet 375 2010 807 815
    • (2010) Lancet , vol.375 , pp. 807-815
    • Lassen, M.R.1    Raskob, G.E.2    Gallus, A.3
  • 39
    • 78650587760 scopus 로고    scopus 로고
    • Apixaban versus enoxaparin for thromboprophylaxis after hip replacement
    • M.R. Lassen, A. Gallus, G.E. Raskob Apixaban versus enoxaparin for thromboprophylaxis after hip replacement N Engl J Med 363 2010 2487 2498
    • (2010) N Engl J Med , vol.363 , pp. 2487-2498
    • Lassen, M.R.1    Gallus, A.2    Raskob, G.E.3
  • 40
    • 84863477329 scopus 로고    scopus 로고
    • The efficacy and safety of pharmacological prophylaxis of venous thromboembolism following elective knee or hip replacement: Systematic review and network meta-analysis
    • [Epub ahead of print]
    • A. Cohen, P. Drost, N. Marchant The efficacy and safety of pharmacological prophylaxis of venous thromboembolism following elective knee or hip replacement: Systematic review and network meta-analysis Clin Appl Thromb/Hemost 2012 [Epub ahead of print]
    • (2012) Clin Appl Thromb/Hemost
    • Cohen, A.1    Drost, P.2    Marchant, N.3
  • 41
    • 84858709224 scopus 로고    scopus 로고
    • Apixaban: An oral direct factor Xa inhibitor
    • D. Jimenez, R.D. Yusen, E. Ramacciotti Apixaban: An oral direct factor Xa inhibitor Adv Ther 29 2012 187 201
    • (2012) Adv Ther , vol.29 , pp. 187-201
    • Jimenez, D.1    Yusen, R.D.2    Ramacciotti, E.3
  • 42
    • 83155193223 scopus 로고    scopus 로고
    • Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients
    • S.Z. Goldhaber, A. Leizorovicz, A.K. Kakkar Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients N Engl J Med 365 2011 2167 2177
    • (2011) N Engl J Med , vol.365 , pp. 2167-2177
    • Goldhaber, S.Z.1    Leizorovicz, A.2    Kakkar, A.K.3
  • 43
    • 80052825103 scopus 로고    scopus 로고
    • Apixaban versus warfarin in patients with atrial fibrillation
    • C.B. Granger, J.H. Alexander, J.J. McMurray Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
    • (2011) N Engl J Med , vol.365 , pp. 981-992
    • Granger, C.B.1    Alexander, J.H.2    McMurray, J.J.3
  • 44
    • 80052836882 scopus 로고    scopus 로고
    • A new era for anticoagulation in atrial fibrillation
    • J.L. Mega A new era for anticoagulation in atrial fibrillation N Engl J Med 365 2011 1052 1054
    • (2011) N Engl J Med , vol.365 , pp. 1052-1054
    • Mega, J.L.1
  • 45
    • 80052162121 scopus 로고    scopus 로고
    • Apixaban with antiplatelet therapy after acute coronary syndrome
    • J.H. Alexander, R.D. Lopes, S. James Apixaban with antiplatelet therapy after acute coronary syndrome N Engl J Med 365 2011 699 708
    • (2011) N Engl J Med , vol.365 , pp. 699-708
    • Alexander, J.H.1    Lopes, R.D.2    James, S.3
  • 46
    • 80052635170 scopus 로고    scopus 로고
    • New anticoagulants: How to deal with treatment failure and bleeding complications
    • R.S. Kazmi, B.A. Lwaleed New anticoagulants: How to deal with treatment failure and bleeding complications Br J Clin Pharmacol 72 2011 593 603
    • (2011) Br J Clin Pharmacol , vol.72 , pp. 593-603
    • Kazmi, R.S.1    Lwaleed, B.A.2
  • 47
    • 77249146517 scopus 로고    scopus 로고
    • Laboratory monitoring of new anticoagulants
    • D.D. Castellone, E.M. Van Cott Laboratory monitoring of new anticoagulants Am J Hematol 85 2010 185 187
    • (2010) Am J Hematol , vol.85 , pp. 185-187
    • Castellone, D.D.1    Van Cott, E.M.2
  • 48
    • 84859971855 scopus 로고    scopus 로고
    • Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors
    • [Epub ahead of print]
    • S. Kaatz, P.A. Kouides, D.A. Garcia Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors Am J Hematol 2012 [Epub ahead of print]
    • (2012) Am J Hematol
    • Kaatz, S.1    Kouides, P.A.2    Garcia, D.A.3
  • 49
    • 77950457738 scopus 로고    scopus 로고
    • Reconstructed recombinant factor Xa as an antidote to reverse anticoagulation by factor Xa inhibitors
    • G. Lu, P. Luan, S. Hollenbach Reconstructed recombinant factor Xa as an antidote to reverse anticoagulation by factor Xa inhibitors J Thromb Haemost 7 suppl 20 2009 107
    • (2009) J Thromb Haemost , vol.7 , Issue.SUPPL. 20 , pp. 107
    • Lu, G.1    Luan, P.2    Hollenbach, S.3
  • 50
    • 74549191939 scopus 로고    scopus 로고
    • Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (third edition)
    • T.T. Horlocker, D.J. Wedel, J.C. Rowlingson Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (third edition) Reg Anesth Pain Med 35 2010 64 101
    • (2010) Reg Anesth Pain Med , vol.35 , pp. 64-101
    • Horlocker, T.T.1    Wedel, D.J.2    Rowlingson, J.C.3
  • 51
    • 78349242482 scopus 로고    scopus 로고
    • Regional anesthesia and antithrombotic agents: Recommendation of the European Society of Anesthesiology
    • W. Gogarten, E. van der Meulen, H. Van Aken Regional anesthesia and antithrombotic agents: Recommendation of the European Society of Anesthesiology Eur J Anaesthesiol 27 2010 999 1015
    • (2010) Eur J Anaesthesiol , vol.27 , pp. 999-1015
    • Gogarten, W.1    Van Der Meulen, E.2    Van Aken, H.3
  • 52
    • 84860526602 scopus 로고    scopus 로고
    • Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation
    • [Epub ahead of print]
    • D.E. Salazar, J. Mendell, H. Kastrissios Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation Thromb Haemost 2012 [Epub ahead of print]
    • (2012) Thromb Haemost
    • Salazar, D.E.1    Mendell, J.2    Kastrissios, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.